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ABSTRAK
Latar belakang: jumlah populasi usia lanjut semakin meningkat di Indonesia. Di lain sisi, prevalensi kanker 
pada pasien usia lanjut juga meningkat. Akan tetapi, studi mengenai faktor klinis terkait kesintasan pasien kanker 
usia lanjut masih terbatas. Studi ini bertujuan untuk mengevaluasi kesintasan pasien kanker usia lanjut dan faktor-
faktor terkait. Metode: studi ini adalah kohort retrospektif. Subyek adalah pasien kanker usia lanjut berusia > 60 
tahun yang berobat pada tahun 2013 – 2015 di RS Kanker Dharmais. Data diambil dari rekam medis, terdiri dari 
jenis kelamin, usia,  jenis kanker, stadium, status performa ECOG, indeks massa tubuh, Charlson Comorbidity Index, 
dan jenis terapi. Analisis kesintasan menggunakan analisis Cox regression untuk mengidentifikasi faktor prognostik 
independen. Hasil: sejumlah 249 pasien dilibatkan dalam studi; median usia adalah 66 tahun dengan rentang usia 
60 – 85 tahun. Jenis kanker terbanyak adalah paru, diikuti dengan payudara, kolorektal dan ginekologi. Median 
waktu kesintasan adalah 24 bulan. Analisis multivariat dilakukan dengan stratifikasi berdasarkan jenis kelamin. 
Kanker stadium lanjut (III-IV) adalah variabel yang bermakna pada kelompok perempuan (hazard ratio [HR] 
2.72; 95% confidence interval [CI] 1.53–4.80; p = 0.001), sedangkan status performa (ECOG 2 – 4) merupakan 
faktor risiko pada kelompok laki-laki (HR 1.82; 95% CI 1.01–3.24; p = 0.04). Kesimpulan: kesintasan pasien 
kanker usia lanjut dipengaruhi berbagai faktor prognostik tradisional. Kanker stadium lanjut merupakan faktor 
prognostik bermakna pada perempuan, sedangkan status performa merupakan faktor prognostik pada laki-laki.
Kata kunci: usia lanjut, kanker, kesintasan.
ABSTRACT
Background: the number of elderly people in Indonesia is increasing. Additionally, cancer prevalence among 
older patients is also increasing. However, studies assessing clinical factors associated with the survival of elderly 
patients with cancer are still lacking. This study aimed to investigate the survival of geriatric patients with cancer 
and associated factors. Methods: this was a retrospective cohort study. Subjects were geriatric patients with 
cancer aged >60 years, enrolled between 2013 and 2015 in Dharmais Cancer Hospital. Data were retrieved 
from medical records and consisted of gender, age, cancer type, stage, Eastern Cooperative Oncology Group 
(ECOG) performance status (PS), body mass index (BMI), Charlson Comorbidity Index, and type of treatment. 
Cox regression analysis was used to identify independent prognostic factors for survival. Results: a total of 249 
patients were enrolled, with a median age of 66 (60–85) years. The most common cancer was of the lung, followed 
by breast, colorectal, and uterine cervical cancers. The median survival time was 24 months. Cox multivariate 
analysis was performed by gender stratification. Advanced stage cancer (III-IV) was identified as the risk factor 
for mortality in female patients (hazard ratio [HR] 2.72; 95% confidence interval [CI] 1.53–4.80; p = 0.001), 
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while poor performance status (ECOG 2 – 4) was the risk factor in male group (HR 1.82; 95% CI 1.01–3.24; 
p = 0.04). Conclusion: the survival of elderly patients with cancer is affected by traditional prognostic factors. 
Advanced cancer stage was significant independent prognostic factor in female patients, while poor performance 
status was significant in male patients.
Keywords: elderly patients, cancer, survival.
INTRODUCTION
The number of elderly people (aged 60 years 
and above) is increasing rapidly in Indonesia. 
Approximately 8.97% (23.4 million) of elderly 
people were estimated in the country in 2017, a 
percentage that is expected to increase to 15% 
in 2035.1 On the other hand, the prevalence of 
non-communicable diseases associated with 
aging − including cancer − is also increasing. 
Among Western populations, and the median age 
of diagnosis of common cancers, such as breast, 
colon, and prostate, is mostly above 60 years.2 
This demographic change carries the challenge 
of managing cancer in elderly patients and led to 
the emergence of geriatric oncology.3
A major issue in the management of elderly 
patients with cancer is the intensity of optimal 
treatment. Elderly patients are a heterogeneous 
group and little information is available regarding 
their ability to tolerate the toxicity of certain 
anticancer regimens.4 A study found that elderly 
patients are submitted to less surgery, more 
frequent single-agent hormonal treatment, and 
less adjuvant systemic treatment compared with 
younger patients. Moreover, elderly patients 
have shorter relative survival than their younger 
counterparts.5
Although developments in medicine and 
socioeconomics have reduced the mortality 
associated with other conditions, cancer death 
remains high. The cancer mortality rate is also 
higher in older than in younger patients. The age-
based cancer mortality for patients over 65 years 
(1,068/100,000) is higher than that of younger 
patients (67/100,000). These data showed that 
the cancer mortality rate was 16 times higher in 
advanced age than in younger ages. More than 
70% of mortality related to solid cancers, such 
as prostate, bladder, colon, uterus, pancreas, 
stomach, rectum, and lung, occurs in patients 
over 65 years of age.6 Another study by Bourdel 
et al.7 found that 1-year mortality rate in elderly 
patients with cancer older than 70 years was 
43.89%.
Recent data from Indonesia showed that 
the cancer prevalence increased from 1.4‰ 
in 2013 to 1.8‰ in 2018.8 Together with the 
increasing life expectancy, geriatric patient 
management will soon be a new challenge for 
medical professionals. However, appropriate 
training and clinical geriatric oncology practice 
are still limited in Asian countries, including 
Indonesia.9 The increasing prevalence of 
cancer and elderly patients, along with the high 
associated mortality rate, argue in favor of more 
geriatric oncology research. Until now, studies 
investigating factors associated with the survival 
of elderly patients with cancer in Indonesia were 
lacking. Therefore, this study aimed to evaluate 
the survival of elderly patients with cancer and 
associated factors.
METHODS
This was a retrospective cohort study 
included patients from Dharmais Cancer 
Hospital (DCH), in Jakarta. Elderly patients 
between January 2013 and December 2015 were 
enrolled based on medical record assessments. 
The elderly were defined as patients aged >60 
years, based on World Health Organization 
criteria for developing countries.10 This study 
was approved by the DCH Ethical Committee on 
April 4, 2018, with the ethical clearance number 
048/KEPK/IV/2018.
Clinical Assessment
Clinical data were obtained from patients’ 
medical records and included age at diagnosis, 
performance status (PS), comorbidities, type of 
cancer, histopathology, stage at diagnosis, and 
type of treatment. The clinical outcome assessed 
was 3-year survival, defined as the time between 
the date of diagnosis and death from any cause. 
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Patients were censored if they were lost to 
follow-up (observed until December 31, 2018).
Criteria for Nutritional Status
Based on the body mass index (BMI) 
criteria for the Asian population, patients 
were classified according to nutritional status 
as underweight (BMI <18.5 kg/m2), normal-
weighted (BMI= 18.5–22.9 kg/m2), overweight 
(BMI = 23.0–24.5 kg/m2), and obese (BMI >25.0 
kg/m2).11 Comorbidities were assessed using 
the Charlson Comorbidity Index (CCI) as the 
total number of non-cancer chronic conditions.12 
Performance status was assessed based on the 
Eastern Cooperative Oncology Group (ECOG) 
PS, scored from 0 to 4.13
Statistical Analysis
Demographic and clinical variables were 
descriptively presented. Differences in overall 
survival between subgroups were calculated 
using the Kaplan–Meier survival analysis.14 The 
log-rank test was used to evaluate the equality of 
survival distributions across different subgroups; 
a p value <0.05 was considered statistically 
significant. The Cox proportional hazards model 
was developed to identify independent prognostic 
factors for overall survival, and expressed as 
the hazard ratio (HR) and corresponding 95% 
confidence interval (CI).15 Statistical analyses 
were performed using Stata version 12.0 for 
Windows PC.
RESULTS
A total of 249 patients were enrolled in this 
study, 60% of which were female. The patients’ 
median age was 66 years, ranging from 60 to 85 
years. A total of 233 solid and 16 blood/lymphoid 
tumors were identified. The most common solid 
cancer was of the lung, followed by breast, 
colorectal, and uterine cervical cancers. Most 
patients were diagnosed at advanced stages (III 
or IV). Other clinical characteristics are shown 
in Table 1.
Survival Analysis
A total of 173 deaths were recorded during 
the study period. The median 3-year survival was 
24.00 (21.24–26.76) months (Figure 1).
The highest mortality was found among 
patients with lung cancer (84.8%), followed by 
Table 1. Characteristics of study subjects (n = 249)
Variables n (%)
Gender (n, %)
 - Male 100 (40.2)
 - Female 149 (59.8)
Educational level
 - <12 years (finished high school or less) 190 (76.3)
 - >12 years (graduate and postgraduate) 59 (23.7)
Nutritional status
 - Underweight 39 (15.7)
 - Normal weight 89 (35.7)
 - Overweight 49 (19.7)
 - Obesity class I 52 (20.9)
 - Obesity class II 20 (8.0)
Anatomical origin of primary tumor
 - Lung 66 (26.5)
 - Breast 64 (25.7)
 - Gastrointestinal 37 (14.9)
 - Gynecological 37 (14.9)
 - Blood and lymphoid 16 (6.4)
 - Urological 15 (6.0)
 - Head and neck 11 (4.4)
 - Skin 2 (0.8)
 - Neurological 1 (0.4)
Stage (n, %)
 - I–II 55 (22.1)
 - III–IV 194 (77.9)
Comorbidity
 - CCI 0 – 1 204 (81.9)
 - CCI 2 – 4 45 (18.1)
ECOG PS
 - 0 – 1 192 (77.1)
 - 2 – 4 57 (22.9)
Figure 1. Kaplan-Meier survival curves of 3-years overall 
survival.
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those with head and neck cancers (27.3%), and 
digestive cancers (27.0%). Univariate analysis 
found that older age (>75 years old), underweight 
(BMI <18.5 kg/m2), poor performance status, 
advanced stage disease and single treatment 
significantly associated with lower overall 
survival (Table 2). Kaplan-Meier curve for 
each significant variable was shown in Figure 
2 – Figure 7.
Table 2. Univariate analysis
Variables HR (95% CI) P
Male 1.40 (1.04-1.89) 0.029
Age >75 years 1.57 (1.05-2.34) 0.028
BMI <18.5 kg/m2 1.64 (1.11-2.42) 0.013
ECOG PS 2-4 1.63 (1.16-2.30) 0.005
Stage III-IV 2.97 (1.89-4.65) <0.001
Single treatment 1.35 (0.99-1.84) 0.05
CCI 0.89 (0.45-1.74) 0.73
Figure 2. Kaplan-Meier survival curves of 3-years overall 
survival based on sex.
All data were treated as closed cohort with 
36 months observation. After data management 
and categorizing all independent variables, 
it was found that gender did not meet the 
Cox proportional assumptions. Therefore, 
multivariate analysis with Cox regression 
was carried out by gender stratification. All 
variables with p<0.20 in univariate analysis were 
conducted to univariate and multivariate analysis 
in each group. Advanced stage cancer (III-IV) 
was identified as the risk factor for mortality in 
female patients (hazard ratio [HR] 2.72; 95% 
Figure 3. Kaplan-Meier survival curves of 3-years overall 
survival based on age group.
Figure 4. Kaplan-Meier survival curves of 3-years overall 
survival based on BMI group.
Figure 5. Kaplan-Meier survival curves of 3-years overall 
survival based on performance status group.
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confidence interval [CI] 1.53–4.80; p = 0.001) 
(Table 4), while poor performance status (ECOG 
2 – 4) was the risk factor in male group (HR 1.82; 
95% CI 1.01–3.24; p = 0.04) (Table 6).
DISCUSSION
Geriatric oncology is a new field of medical 
research in Indonesia, and this study was a 
preliminary assessment of prognostic factors 
affecting the survival of elderly patients with 
cancer. In this study, cancer staging was not 
merely the prognostic factor assessed. Other 
important variables like age, nutritional status 
(represented by BMI) and performance status 
were also assessed. Aging is a complex process. 
Pre-treatment condition of elderly patients is 
very important to be assessed before giving 
any treatment.16 Assessing psychosocial aspect 
such as level of education, family support, and 
psychomental state are also necessary. A recent 
systematic review found that advanced age, low 
income, low socioeconomic status, presence 
of comorbidities, advanced stage at diagnosis, 
and poor tumor grade were associated with 
lower survival.17 However, since this was a 
retrospective study and psychosocial assessment 
was not routinely done, we did not do further 
analysis.
Figure 6. Kaplan-Meier survival curves of 3-years overall 
survival based on treatment group.
Figure 7. Kaplan-Meier survival curves of 3-years overall 
survival based on disease stage.
Table 3. Univariate analysis in female patients (n=149)
Variables HR (95% CI) P
Age >75 years 1.74 (1.00-3.03) 0.048
BMI <18.5 kg/m2 2.10 (1.22-3.60) 0.007
ECOG PS 2-4 1.58 (1.00-2.51) 0.049
Stage III-IV 3.19 (1.83-5.55) <0.001
Single treatment 1.49 (0.99-2.24) 0.05
CCI 1.49 (0.60-3.69) 0.41




HR (95% CI) P
Age >75 years 1.49 (0.82-2.69) 0.19
BMI <18.5 kg/m2 1.57 (0.87-2.81) 0.13
ECOG PS 2-4 1.42 (0.88-2.27) 0.15
Stage III-IV 2.72 (1.53-4.80) 0.001
Multiple treatments 1.51 (0.99-2.29) 0.05
Table 5. Univariate analysis in male patients (n=100)
Variables HR (95% CI) p
Age >75 years 1.51 (0.72-3.14) 0.27
BMI <18.5 kg/m2 1.29 (0.74-2.25) 0.37
ECOG PS 2-4 1.86 (1.08-3.17) 0.02
Stage III-IV 2.07 (0.95-4.51) 0.07
Multiple treatments 0.96 (0.59-1.55) 0.86
CCI 0.51 (0.19-1.40) 0.19




HR (95% CI) p
Age >75 years 1.64 (0.77-3.50) 0.19
BMI <18.5 kg/m2 1.13 (0.62-2.05) 0.68
ECOG PS 2-4 1.82 (1.01-3.24) 0.04
Stage III-IV 2.16 (0.98-4.73) 0.05
Multiple treatments 1.06 (-.65-1.74) 0.81
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Age is one of the traditional factors that 
is commonly related to mortality in cancer. 
However, multivariate analysis in this study 
failed to find significant association between 
age and survival in cancer patients. This 
findings showed that chronological age has 
limitation in evaluating patient’s physiological 
function, health and aging status, therefor it 
is not always significantly associated with 
mortality. Nowadays, biological age (estimated 
by biomarkers) is famously known as the “real 
age” which can reflect health status with aging. 
Further studies of elderly using biological age 
are needed.
Sex is an important factor in pathogenesis, 
diagnosis, and prognosis in many diseases, 
including cancer. Several studies showed that 
female gender was associated with longer 
survival.17,18 Our study found that female had 
better survival than male. However, gender did 
not meet Cox proportional hazard assumption in 
further analysis. A study by Cook et al.19 found 
that sex-related cancer disparities are more 
strongly related to etiology than prognosis.
 The PS (Karnofsky or ECOG) is traditionally 
used to assess the functional status in elderly 
patients with cancer and determines their 
ability to tolerate anticancer treatments. In the 
last few decades, the Comprehensive Geriatric 
Assessment (CGA) has been added to geriatric 
oncology practice to evaluate the tolerability of 
the elderly before receiving chemotherapy. CGA 
also indicated that elderly patients with cancer 
have numerous health problems associated 
with survival, such as functional impairment, 
malnutrition, and comorbidities.4 Growing 
evidence demonstrates that CGA can predict 
mortality in elderly patients with cancer.20 
However, as CGA is not used in our hospital, 
we were unable to evaluate certain aspects of 
geriatric patients, as social functioning, activities 
of daily living, and psychological function. 
Univariate analysis showed that subjects with 
worse PS (ECOG 2 – 4) had lower OS compared 
to subjecta with better PS. In gender-stratified 
multivariate analysis of this study, ECOG 2 – 4 
was also associated with mortality. In general 
geriatric population, functional status have been 
found to be a predictor of survival.21 For elderly 
with cancer, performance status may affect the 
ability and respond to treatment. Patients with 
poor performance status are associated with 
increased risk of treatment toxicity and poor 
outcomes compared to patients with better 
performance status.22
The correlation between cancer stage and 
survival has been widely investigated. As 
expected, survival in advanced stage cancer 
is lower than early stage.23 A study in breast 
cancer patients showed that advanced stage were 
associated with higher mortality.24 his similar 
finding was found in this study. In multivariate 
analysis, advanced stage cancer was associated 
with lower survival, especially in female group. 
In certain types of cancer that are more common 
in men such as prostate cancer and Hodgkin’s 
lymphoma, stage does not significantly affect the 
decrease in survival.23 This can be the reason of 
insignificant association between cancer stage 
and survival in male group.
Nutritional status is an important prognostic 
factor in elderly patients. The BMI is one of 
several methods to measure the nutritional status. 
In elderly people, reduced weight or BMI is a 
complex condition resulting from reduced dietary 
intake, loss of muscle mass (sarcopenia), and 
cachexia due to cancer, with potential prognostic 
implications.25 Undernutrition can be found in 
66% of elderly patients with cancer.26 Low BMI 
and weight loss are associated with an increased 
risk of death in the elderly population.27 Severe 
malnutrition has been associated with poor 
prognosis in colorectal cancer.28 In the current 
study, patients with undernutrition status had 
lower survival (Figure 4). However, multivariate 
analysis failed to show prognostic role of BMI, 
suggesting that it was a confounding factor, 
affected by more advanced stage and related to 
poor PS. However, the use of BMI as a single 
nutritional status measure has a major drawback, 
since it cannot accurately reflect muscle mass or 
adiposity. In line with this finding, a study among 
elderly people aged ≥70 years without cancer 
found that obesity was inversely associated with 
mortality.29 Another study among patients with 
non-metastatic colorectal cancer showed that 
low muscle mass, high adiposity, or both were 
associated with worse survival, with the lowest 
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risk of mortality found for BMI between 25 and 
<30 kg/m2. In CT scan, patients in this subgroup 
seemed to have adequate muscle mass and low 
fat.30 This could be the reason why patients with 
low BMI had poor survival outcomes.
The treatment of elderly patients with cancer 
remains a challenge due to the complexity 
of organ function decline, comorbidities, 
impairments, and social factors.31 The toxicity 
of anticancer therapies is potentially higher in 
elderly patients,32 but evidence is limited as most 
clinical trials have not enrolled elderly patients. 
In this study, the net effect of multimodal 
treatment compared with single treatment was 
investigated and failed to show significant 
association with survival. Single treatment with 
a cytotoxic agent is usually recommended for 
elderly patients with advanced disease. However, 
several studies showed different results. Study by 
Thiels et al.33 found that multimodality treatment 
in elderly patients with stage III rectal cancer 
resulted in better outcomes. Another study by 
Coate et al.34 also showed that multimodality 
treatment in elderly cancer patients could provide 
better outcomes if given to fit-elderly and for 
curative goals.
Based on the current results, the authors 
encourage adequate management of nutrition 
in elderly patients with cancer. Geriatric 
oncology team should also involve nutritionists 
in management of nutrition for elderly cancer 
patients. Whenever feasible, exercise should also 
be advised to increase muscle mass and reduce 
fat. Further studies are required to elucidate the 
optimal weight and body composition able to 
tolerate multiple treatments and produce better 
clinical outcomes. Contrary to current beliefs, 
multiple treatments with optimal regimens can be 
offered to this patient population, as the elderly are 
still responsive to anticancer treatment. Significant 
association between cancer stage and survival 
emphasizes the importance of early detection.
This study has some limitations. First, it 
had a retrospective design, based on medical 
record data. Therefore, the clinical data retrieved 
were limited and no further assessments could 
be performed regarding other characteristics 
of geriatric patients. However, some important 
prognostic factors could still be assessed and used 
for analysis. Second, all patients were included 
and a specific cancer type was not evaluated. 
It is possible that survival time is affected by 
tumor type, as observed in lung cancer, which 
has the highest mortality rate. Further studies 
with prospective design using CGA are needed. 
CONCLUSION
The survival of elderly patients with 
cancer is affected by traditional prognostic 
factors. Advanced cancer stage was significant 
independent prognostic factor in female patients, 
while poor performance status was significant in 
male patients.
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